Worldwide News

Aerogen has released details of a collaborative effort to support global pharmaceutical companies developing COVID-19 vaccines and therapies. To date, more than ten million patients globally have been treated safely and effectively with Aerogen’s drug delivery technology. As the global scientific community rallies against the pandemic, there has been interest in inhaled delivery of antiviral […]

Immunai has joined forces with Baylor College of Medicine to bring more targeted and effective cancer therapies to market. Leveraging Immunai’s single-cell technology and artificial intelligence, Baylor and Immunai will analyse natural killer T (NKT) cells and genetically engineer them into immunotherapies that target a variety of cancers, including solid tumours. While some immunotherapies like […]

CAS and the Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life science and healthcare R&D, have launched a new Pistoia Alliance Chemical Safety Library platform. This resource aims to mitigate the serious risks researchers working with potentially hazardous chemicals face due to unanticipated chemical reaction outcomes by enabling scientists […]

Author Julia Milzer, CU Anschutz  The CU Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz has announced a new drug discovery technology that can cut the screening time for new drug therapies by half. It will enable rapid and cost-effective screening of hundreds of thousands of potential therapies for diseases. The University of […]

DDW has expanded. The longstanding first-choice publication for the drug discovery and development community now offers more content as well as more ways for you to access it. You told us what you wanted and we listened Established in 1999, DDW is the go-to brand for the industry. Following a reader survey earlier this year, […]

hVIVO, has signed a contract with the UK government to develop a COVID-19 (SARS-CoV-2) human challenge study model. The model development involves the manufacture of the challenge virus and the first-in-human characterisation study for this virus. The contract starts immediately and could be worth approximately £10 million to hVIVO – a subsidiary of Open Orphan […]

The Analytica conference accompanies Analytica 2020, which is currently taking place virtually until 23 October. Key topics in focus at the event are  antibiotic resistance and the ‘laboratory of the future’. The number of microbes that are resistant to certain classes of antibiotics is increasing – hampering therapy. Humans and animals introduce germs and antibiotic-resistant […]

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will show you how advanced flow cytometry can be used to effectively evaluate immuno-oncology drugs using physiologically relevant assays. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will be hosted by DDW and […]

The world’s first participants to take part in a phase III trial of the Novavax COVID-19 vaccine candidate have  been recruited at one of the new NIHR National Patient Recruitment Centres (NPRC) based in Blackpool, UK. US-based biotechnology firm, Novavax, launched the phase III clinical trial of a potential COVID-19 vaccine, NVX-CoV2373, in the UK […]

Evotec’s Seattle-based subsidiary, Just–Evotec Biologics has received a grant from the Bill & Melinda Gates Foundation as part of the COVID-19 Therapeutics Accelerator to enable the development and production of monoclonal antibody (mAb) candidates for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries. Under the grant, Just–Evotec Biologics will […]